Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine desensitization in ulcerative colitis patients with prior intolerance
NL-OMON34817Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Salcrozine in autoimmune colitis, sponsored by University Medical Center Groningen. Primary endpoints: Successful desensitization to mesalazine and Reproducibility of prior intolerance during rechallenge. Started Mar 2010; status: active, not recruiting.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON34817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34817.